1 Min Read
May 3 (Reuters) - Arrowhead Pharmaceuticals Inc
* Arrowhead reports fiscal 2017 second quarter results
* Qtrly loss per share $0.08
* Q2 revenue $9 million versus $43,750 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.